ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
UroGen Pharma Ltd

UroGen Pharma Ltd (URGN)

16.94
0.00
(0.00%)
Closed July 24 4:00PM
0.00
0.00
(0.00%)

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 16.6M16.1M18.09M17.19M21.14M20.85M23.53M18.78M
Operating Income -18.72M-18.09M-20.28M-22.05M-15.38M-13.5M-14.61M-25.74M
Pre Tax Income -26.66M-25.12M-28.18M-30.19M-24.08M-21.89M-22.16M-32.23M
Net Income -26.69M-25.83M-28.87M-30.21M-24.14M-21.88M-26.02M-32.29M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -18.62M-18.05M-20.35M-22.06M-15.41M-13.47M-13.8M-25.92M
EBITDA -18.48M-17.85M-20.05M-21.83M-15.17M-13.31M-14.42M-25.62M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 17.53M8.16M1.13M18k11.8M48.04M64.36M82.71M
Operating Income 798k-19.95M-77.18M-109.48M-126.74M-92.29M-79.04M-65.54M
Pre Tax Income -1.94M-19.98M-75.53M-105.15M-125.11M-109.37M-108.03M-98.32M
Net Income -1.94M-20M-75.66M-105.15M-128.48M-110.82M-109.78M-102.24M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.259-1.056-3.534-4.01-4.696-4.007-3.876-2.835
EBIT 798k-19.95M-77.3M-109.76M-126.74M-92.29M-78.97M-64.7M
EBITDA 1.01M-19.74M-76.76M-109.18M-126.32M-91.46M-78.12M-64.73M